RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $691,535 | -75.7% | 34,926 | -70.5% | 0.13% | -77.3% |
| Q3 2022 | $2,850,000 | -64.8% | 118,463 | -73.3% | 0.58% | -64.4% |
| Q2 2022 | $8,096,000 | -17.0% | 443,619 | 0.0% | 1.62% | +10.7% |
| Q1 2022 | $9,755,000 | -40.1% | 443,619 | 0.0% | 1.46% | -35.8% |
| Q4 2021 | $16,294,000 | -13.8% | 443,619 | -27.1% | 2.28% | +2.6% |
| Q3 2021 | $18,899,000 | -24.0% | 608,663 | -22.2% | 2.22% | -29.9% |
| Q2 2021 | $24,879,000 | +12.1% | 782,593 | -21.7% | 3.18% | +9.7% |
| Q1 2021 | $22,200,000 | +0.2% | 1,000,000 | -10.9% | 2.89% | -9.6% |
| Q4 2020 | $22,164,000 | -50.1% | 1,122,237 | -18.7% | 3.20% | -48.2% |
| Q3 2020 | $44,459,000 | -2.6% | 1,380,704 | -12.2% | 6.18% | -3.5% |
| Q2 2020 | $45,626,000 | – | 1,572,237 | – | 6.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |